Description
This product utilizes CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD229 ( clone 2C58Q). We employs the AAV (CMV-Cy3-c-Fos-XbaI) vector components and the SynExpress system of the single base pair Knockout/Balancing feedback for a robust and sustained response against cancers.
Host
Human
Target
CD229
Clone
2C58Q
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.92
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.